Trump 100% Tariff on Generic Drug Imports Effective 2028

President Trump announced a proposed 100% tariff on generic drug imports starting in 2028. This decision aims to protect domestic pharmaceutical companies and encourage local production. The measure might significantly affect the pricing of generic drugs in the U.S. market, potentially raising costs for consumers. Investors in pharmaceutical companies should monitor the long-term implications of this move on the industry's dynamics and pricing structures.